Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-19)Premium Content

Five Prime Therapeutics Inc (FPRX)

2014-10-31@06:00:57 ET
Form 4: Update Filing for Five Prime Therapeutics Inc (FPRX) (VKR)

2014-10-31@06:00:43 ET
Form 4: Update Filing for Five Prime Therapeutics Inc (FPRX) (VKR)

2014-10-31@06:00:30 ET
Form 4: Update Filing for Five Prime Therapeutics Inc (FPRX) (VKR)

2014-10-23@21:21:55 ET
Five Prime Therapeutics, Inc.Corporate Event Announcement Notice (WSH)

2014-10-23@17:18:52 ET
8-K: FIVE PRIME THERAPEUTICS INC (EDK)

2014-10-23@16:05:40 ET
Five Prime Therapeutics Announces Expansion of Respiratory Disease Research Collaboration and License Agreement With GSK (PMZ)

2014-10-22@22:21:00 ET
Five Prime Therapeutics, Inc.Corporate Event Announcement Notice (WSH)

2014-10-22@21:25:51 ET
Five Prime Therapeutics, Inc.Corporate Event Announcement Notice (WSH)

2014-10-03@05:21:12 ET
Form 3: Initial Filing for Five Prime Therapeutics Inc (FPRX) (VKR)

2014-10-02@16:05:17 ET
Five Prime Therapeutics Appoints Bill Ringo to Its Board of Directors (PMZ)

2014-09-19@21:05:08 ET
Five Prime Therapeutics, Inc.Corporate Event Announcement Notice (WSH)

2014-09-18@21:03:57 ET
Five Prime Therapeutics, Inc.Corporate Event Announcement Notice (WSH)

2014-09-18@06:41:09 ET
Five Prime Therapeutics elects Dr. Robert Sikorski as VP of Global Clinical Development (MTO)

2014-09-17@16:05:11 ET
Five Prime Therapeutics Appoints Dr. Robert Sikorski as Vice President of Global Clinical Development (PMZ)

2014-09-15@16:39:32 ET
Five Prime Therapeutics Announces Option Exercise by GlaxoSmithKline for a Commercial License to a Novel Muscle Disease Target (PMZ)